A prospective, descriptive cohort study evaluating the prevalence and incidence of exocrine pancreatic insufficiency in patients with pancreatic cancer.
- Conditions
- pancreatic exocrine insufficiency1001567410017991
- Registration Number
- NL-OMON35011
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Patients who are considered for this trial:
- Age >= 18 years.
- Malignant tumours of the pancreas, distal cholangiocarcinoma and papillary tumours proven by means of cytology/histology and/or radiology.
- are capable and willing to follow instructions given by the physician.
The following are considered as exclusion criteria:
- Subjects who are unwilling or unable to understand and participate in the study and sign the informed consent.
- Pre-existent EPI
- Pre-existent malabsorption (short bowel disease, IBD, other)
- Any known gastro-intestinal disease or major gastrointestinal surgery that could potentially affect the intestinal absorption or metabolism of fat
- Total pancreatectomy
- Gastroparesis
- Pregnancy/lactation
- Patients who are suspected not to be reliable in participating in this study, based on the physicians experience.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method